Legal status in Estonia

Per-substance legal status for Estonia, from sourced statutes where available. Legal information, not legal advice; drug laws change, so confirm with the destination’s embassy or drug authority before you travel.

88 confirmed substances0 not individually verifiedLast updated September 20, 2026

Confirmed legal status

1P-LSD

Legal status: 1P-LSD is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for 1P-LSD reads «1-propionüül-lüsergiinhappe dietüülamiid (1P-LSD; 1p-LSD)». The source does not state whether that entry names 1P-LSD itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for 1P-LSD, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of 1P-LSD can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of 1P-LSD is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for 1P-LSD. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for 1P-LSD names the annex and the entry «1-propionüül-lüsergiinhappe dietüülamiid (1P-LSD; 1p-LSD)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for 1P-LSD as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for 1P-LSD in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for 1P-LSD appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «1-propionüül-lüsergiinhappe dietüülamiid (1P-LSD; 1p-LSD)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, 1P-LSD, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «1-propionüül-lüsergiinhappe dietüülamiid (1P-LSD · 1p-LSD)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

1P-LSD in Estonia, full detail →

2-FDCK

Legal status: 2-FDCK is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for 2-FDCK reads «2-fluoroketamiin; 2-fluorodeskloroketamiin (2-FK; 2-FDCK)». The source does not state whether that entry names 2-FDCK itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for 2-FDCK, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of 2-FDCK can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of 2-FDCK is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for 2-FDCK. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for 2-FDCK names the annex and the entry «2-fluoroketamiin; 2-fluorodeskloroketamiin (2-FK; 2-FDCK)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for 2-FDCK as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for 2-FDCK in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for 2-FDCK appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «2-fluoroketamiin; 2-fluorodeskloroketamiin (2-FK; 2-FDCK)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, 2-FDCK, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «2-fluoroketamiin · 2-fluorodeskloroketamiin (2-FK · 2-FDCK)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

2-FDCK in Estonia, full detail →

25I-NBOMe

Legal status: 25I-NBOMe is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for 25I-NBOMe reads «2-(4-jodo-2,5-dimetoksüfenüül)-N-[(2-metoksüfenüül)metüül]etaanamiin (25I-NBOMe)». The source does not state whether that entry names 25I-NBOMe itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for 25I-NBOMe, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of 25I-NBOMe can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of 25I-NBOMe is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for 25I-NBOMe. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for 25I-NBOMe names the annex and the entry «2-(4-jodo-2,5-dimetoksüfenüül)-N-[(2-metoksüfenüül)metüül]etaanamiin (25I-NBOMe)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for 25I-NBOMe as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for 25I-NBOMe in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for 25I-NBOMe appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «2-(4-jodo-2,5-dimetoksüfenüül)-N-[(2-metoksüfenüül)metüül]etaanamiin (25I-NBOMe)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, 25I-NBOMe, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «2-(4-jodo-2,5-dimetoksüfenüül)-N-[(2-metoksüfenüül)metüül]etaanamiin (25I-NBOMe)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

25I-NBOMe in Estonia, full detail →

2C-B

Legal status: 2C-B is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for 2C-B reads «1-(4-bromo-2,5-dimetoksüfenüül)-2-aminoetaan (2C-B; Nexus; BDMPEA)». The source does not state whether that entry names 2C-B itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for 2C-B, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of 2C-B can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of 2C-B is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for 2C-B. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for 2C-B names the annex and the entry «1-(4-bromo-2,5-dimetoksüfenüül)-2-aminoetaan (2C-B; Nexus; BDMPEA)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for 2C-B as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for 2C-B in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for 2C-B appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «1-(4-bromo-2,5-dimetoksüfenüül)-2-aminoetaan (2C-B; Nexus; BDMPEA)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, 2C-B, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «1-(4-bromo-2,5-dimetoksüfenüül)-2-aminoetaan (2C-B · Nexus · BDMPEA)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

2C-B in Estonia, full detail →

2C-E

Legal status: 2C-E is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for 2C-E reads «2,5-dimetoksü-4-etüülfenetüülamiin (2C-E)». The source does not state whether that entry names 2C-E itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for 2C-E, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of 2C-E can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of 2C-E is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for 2C-E. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for 2C-E names the annex and the entry «2,5-dimetoksü-4-etüülfenetüülamiin (2C-E)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for 2C-E as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for 2C-E in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for 2C-E appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «2,5-dimetoksü-4-etüülfenetüülamiin (2C-E)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, 2C-E, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «2,5-dimetoksü-4-etüülfenetüülamiin (2C-E)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

2C-E in Estonia, full detail →

2C-I

Legal status: 2C-I is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for 2C-I reads «2,5-dimetoksü-4-jodofenetüülamiin (2C-I)». The source does not state whether that entry names 2C-I itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for 2C-I, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of 2C-I can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of 2C-I is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for 2C-I. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for 2C-I names the annex and the entry «2,5-dimetoksü-4-jodofenetüülamiin (2C-I)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for 2C-I as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for 2C-I in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for 2C-I appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «2,5-dimetoksü-4-jodofenetüülamiin (2C-I)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, 2C-I, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «2,5-dimetoksü-4-jodofenetüülamiin (2C-I)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

2C-I in Estonia, full detail →

2C-T-7

Legal status: 2C-T-7 is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for 2C-T-7 reads «2,5-dimetoksü-4-(n)-propüültiofenetüülamiin (2C-T-7)». The source does not state whether that entry names 2C-T-7 itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for 2C-T-7, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of 2C-T-7 can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of 2C-T-7 is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for 2C-T-7. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for 2C-T-7 names the annex and the entry «2,5-dimetoksü-4-(n)-propüültiofenetüülamiin (2C-T-7)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for 2C-T-7 as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for 2C-T-7 in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for 2C-T-7 appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «2,5-dimetoksü-4-(n)-propüültiofenetüülamiin (2C-T-7)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, 2C-T-7, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «2,5-dimetoksü-4-(n)-propüültiofenetüülamiin (2C-T-7)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

2C-T-7 in Estonia, full detail →

3-MMC

Legal status: 3-MMC is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for 3-MMC reads «3-metüülmetkatinoon (3-MMC)». The source does not state whether that entry names 3-MMC itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for 3-MMC, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of 3-MMC can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of 3-MMC is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for 3-MMC. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for 3-MMC names the annex and the entry «3-metüülmetkatinoon (3-MMC)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for 3-MMC as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for 3-MMC in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for 3-MMC appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «3-metüülmetkatinoon (3-MMC)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, 3-MMC, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «3-metüülmetkatinoon (3-MMC)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

3-MMC in Estonia, full detail →

4-AcO-DMT

Legal status: 4-AcO-DMT is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for 4-AcO-DMT reads «4-atsetoksü-N,N-dimetüültrüptamiin (4-AcO-DMT)». The source does not state whether that entry names 4-AcO-DMT itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for 4-AcO-DMT, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of 4-AcO-DMT can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of 4-AcO-DMT is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for 4-AcO-DMT. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for 4-AcO-DMT names the annex and the entry «4-atsetoksü-N,N-dimetüültrüptamiin (4-AcO-DMT)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for 4-AcO-DMT as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for 4-AcO-DMT in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for 4-AcO-DMT appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «4-atsetoksü-N,N-dimetüültrüptamiin (4-AcO-DMT)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, 4-AcO-DMT, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «4-atsetoksü-N,N-dimetüültrüptamiin (4-AcO-DMT)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

4-AcO-DMT in Estonia, full detail →

4-HO-MET

Legal status: 4-HO-MET is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for 4-HO-MET reads «4-hüdroksü-N-metüül-N-etüültrüptamiin (4-HO-MET)». The source does not state whether that entry names 4-HO-MET itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for 4-HO-MET, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of 4-HO-MET can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of 4-HO-MET is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for 4-HO-MET. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for 4-HO-MET names the annex and the entry «4-hüdroksü-N-metüül-N-etüültrüptamiin (4-HO-MET)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for 4-HO-MET as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for 4-HO-MET in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for 4-HO-MET appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «4-hüdroksü-N-metüül-N-etüültrüptamiin (4-HO-MET)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, 4-HO-MET, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «4-hüdroksü-N-metüül-N-etüültrüptamiin (4-HO-MET)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

4-HO-MET in Estonia, full detail →

5-MeO-DMT (Bufo / Toad)

Legal status: 5-MeO-DMT is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for 5-MeO-DMT reads «5-metoksü-N,N-dimetüültrüptamiin (5-MeO-DMT)». The source does not state whether that entry names 5-MeO-DMT itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for 5-MeO-DMT, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of 5-MeO-DMT can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of 5-MeO-DMT is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for 5-MeO-DMT. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for 5-MeO-DMT names the annex and the entry «5-metoksü-N,N-dimetüültrüptamiin (5-MeO-DMT)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for 5-MeO-DMT as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for 5-MeO-DMT in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for 5-MeO-DMT appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «5-metoksü-N,N-dimetüültrüptamiin (5-MeO-DMT)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, 5-MeO-DMT, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «5-metoksü-N,N-dimetüültrüptamiin (5-MeO-DMT)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

5-MeO-DMT (Bufo / Toad) in Estonia, full detail →

6-APB

Legal status: 6-APB is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for 6-APB reads «6-(2-aminopropüül)bensofuraan (6-APB)». The source does not state whether that entry names 6-APB itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for 6-APB, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of 6-APB can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of 6-APB is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for 6-APB. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for 6-APB names the annex and the entry «6-(2-aminopropüül)bensofuraan (6-APB)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for 6-APB as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for 6-APB in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for 6-APB appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «6-(2-aminopropüül)bensofuraan (6-APB)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, 6-APB, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «6-(2-aminopropüül)bensofuraan (6-APB)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

6-APB in Estonia, full detail →

7-Hydroxymitragynine (7-OH)

Legal status: 7-hydroxymitragynine is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for 7-hydroxymitragynine reads «7-hüdroksümitragüniin». The source does not state whether that entry names 7-hydroxymitragynine itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for 7-hydroxymitragynine, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of 7-hydroxymitragynine can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of 7-hydroxymitragynine is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for 7-hydroxymitragynine. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for 7-hydroxymitragynine names the annex and the entry «7-hüdroksümitragüniin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for 7-hydroxymitragynine as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for 7-hydroxymitragynine in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for 7-hydroxymitragynine appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «7-hüdroksümitragüniin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, 7-hydroxymitragynine, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «7-hüdroksümitragüniin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

7-Hydroxymitragynine (7-OH) in Estonia, full detail →

Adderall

Legal status: Adderall is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for Adderall reads «Amfetamiin; deksamfetamiin». The source does not state whether that entry names Adderall itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for Adderall, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of Adderall can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of Adderall is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for Adderall. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for Adderall names the annex and the entry «Amfetamiin; deksamfetamiin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for Adderall as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for Adderall in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for Adderall appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Amfetamiin; deksamfetamiin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Adderall, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Amfetamiin · deksamfetamiin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Adderall in Estonia, full detail →

Alcohol

Legal status: Alcohol is not listed in the Estonian narcotic and psychotropic schedule. It is governed instead by the Alcohol Act, Alkoholiseadus, which is a separate regulatory regime and not the narcotic schedule. No entry for alcohol was located in Lists I to VI of Annex 1. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to alcohol by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach alcohol, because those penalties attach to the narcotic schedule and alcohol is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that alcohol is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for alcohol in Estonia, because the narcotic schedule does not carry it. The governing regime is the Alcohol Act, Alkoholiseadus, which is a separate regulatory regime and not the narcotic schedule. Whether alcohol is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for alcohol as unread rather than as open.
Documentation: Carry alcohol as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for alcohol and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for alcohol appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Alcohol, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for alcohol, and records no search terms for this row · the governing regime recorded by the source is the Alcohol Act, Alkoholiseadus, which is a separate regulatory regime and not the narcotic schedule · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Alcohol in Estonia, full detail →

Amanita muscaria

Legal status: Amanita muscaria is not listed in the Estonian narcotic and psychotropic schedule. No entry for Amanita muscaria was located in Lists I to VI of Annex 1. No entry for the mushroom, for muscimol or for ibotenic acid was located. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to Amanita muscaria by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach Amanita muscaria, because those penalties attach to the narcotic schedule and Amanita muscaria is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that Amanita muscaria is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for Amanita muscaria in Estonia, because the narcotic schedule does not carry it. The governing regime is no regime named in what was read, which is a gap rather than a permission. Whether Amanita muscaria is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for Amanita muscaria as unread rather than as open.
Documentation: Carry Amanita muscaria as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for Amanita muscaria and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for Amanita muscaria appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Amanita muscaria, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for Amanita muscaria, and records no search terms for this row · the governing regime recorded by the source is no regime named in what was read, which is a gap rather than a permission · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Amanita muscaria in Estonia, full detail →

Amphetamine

Legal status: Amphetamine is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for amphetamine reads «Amfetamiin». The source does not state whether that entry names amphetamine itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for amphetamine, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of amphetamine can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of amphetamine is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for amphetamine. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for amphetamine names the annex and the entry «Amfetamiin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for amphetamine as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for amphetamine in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for amphetamine appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Amfetamiin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Amphetamine, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Amfetamiin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Amphetamine in Estonia, full detail →

Amyl Nitrite

Legal status: Amyl nitrite is not listed in the Estonian narcotic and psychotropic schedule. No entry for amyl nitrite was located in Lists I to VI of Annex 1. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to amyl nitrite by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach amyl nitrite, because those penalties attach to the narcotic schedule and amyl nitrite is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that amyl nitrite is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for amyl nitrite in Estonia, because the narcotic schedule does not carry it. The governing regime is no regime named in what was read, which is a gap rather than a permission. Whether amyl nitrite is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for amyl nitrite as unread rather than as open.
Documentation: Carry amyl nitrite as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for amyl nitrite and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for amyl nitrite appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Amyl nitrite, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for amyl nitrite, and records no search terms for this row · the governing regime recorded by the source is no regime named in what was read, which is a gap rather than a permission · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Amyl Nitrite in Estonia, full detail →

Ayahuasca

Legal status: Ayahuasca is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for ayahuasca reads «Dimetüültrüptamiin (DMT)». That same entry is the one relied on for DMT, so it is not specific to ayahuasca and the row rests on a shared entry rather than on a name of its own. The source does not state whether that entry names ayahuasca itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for ayahuasca, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of ayahuasca can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of ayahuasca is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for ayahuasca. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for ayahuasca names the annex and the entry «Dimetüültrüptamiin (DMT)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for ayahuasca as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for ayahuasca in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for ayahuasca appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Dimetüültrüptamiin (DMT)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Ayahuasca, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Dimetüültrüptamiin (DMT)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Ayahuasca in Estonia, full detail →

Barbiturates

Legal status: Barbiturates is a family label rather than a single scheduled entry, and in Estonia it has no single schedule result. Annex 1 to Minister of Social Affairs Regulation No 73 controls named members of the family, among them phenobarbital and pentobarbital, so the legal answer depends on which member is identified rather than on the family name. The Narcotic Drugs and Psychotropic Substances Act prohibits handling of a listed member except for authorised medical, scientific and enforcement purposes. A product described only as barbiturates has not yet been identified for this purpose. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of any member of the barbiturates family can carry one. The ceiling for a listed member is life imprisonment under Penal Code section 184(2) with a superscript one, reached when section 184 conduct is committed for large financial gain or by a criminal organisation, with 6 to 20 years in the band below it. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). There is no class wide gram number for barbiturates and there cannot be one, because the quantity test applies to the identified member. What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure.
If prescribed / medical: Several members of the barbiturates family are prescription medicines in Estonia and the family label does not tell you which regime applies to the product in your hand. The Act permits handling for authorised medical, scientific and enforcement purposes, so a lawful route exists for a member that is a licensed medicine. Regulation No 73 divides its schedule into six lists, Lists I to VI, and the source read for barbiturates does not record which list carries any individual member. Identify the member, then ask the State Agency of Medicines about that member. Treat the route as unread for the family as a whole.
Documentation: Carry the prescription and the original dispensing packaging naming the specific member you hold, not the family name barbiturates, and confirm the position with the State Agency of Medicines before you travel. That is the carriage answer, and the reason it insists on the member is that Estonian law attaches to the member and not to the family. No traveller permit scheme, declaration form or carriage allowance for barbiturates appears in what was read. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, together with the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, and the source records the family as member based, naming phenobarbital and pentobarbital among the controlled members.

Estonia, Barbiturates, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73, which controls named members of the family including phenobarbital and pentobarbital and prints no entry for the family label itself · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Barbiturates in Estonia, full detail →

Benzodiazepines

Legal status: Benzodiazepines is a family label rather than a single scheduled entry, and in Estonia it has no single schedule result. Annex 1 to Minister of Social Affairs Regulation No 73 controls named members of the family, among them alprazolam, diazepam and lorazepam, so the legal answer depends on which member is identified rather than on the family name. The Narcotic Drugs and Psychotropic Substances Act prohibits handling of a listed member except for authorised medical, scientific and enforcement purposes. A product described only as benzodiazepines has not yet been identified for this purpose. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of any member of the benzodiazepines family can carry one. The ceiling for a listed member is life imprisonment under Penal Code section 184(2) with a superscript one, reached when section 184 conduct is committed for large financial gain or by a criminal organisation, with 6 to 20 years in the band below it. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). There is no class wide gram number for benzodiazepines and there cannot be one, because the quantity test applies to the identified member. What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure.
If prescribed / medical: Several members of the benzodiazepines family are prescription medicines in Estonia and the family label does not tell you which regime applies to the product in your hand. The Act permits handling for authorised medical, scientific and enforcement purposes, so a lawful route exists for a member that is a licensed medicine. Regulation No 73 divides its schedule into six lists, Lists I to VI, and the source read for benzodiazepines does not record which list carries any individual member. Identify the member, then ask the State Agency of Medicines about that member. Treat the route as unread for the family as a whole.
Documentation: Carry the prescription and the original dispensing packaging naming the specific member you hold, not the family name benzodiazepines, and confirm the position with the State Agency of Medicines before you travel. That is the carriage answer, and the reason it insists on the member is that Estonian law attaches to the member and not to the family. No traveller permit scheme, declaration form or carriage allowance for benzodiazepines appears in what was read. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, together with the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, and the source records the family as member based, naming alprazolam, diazepam and lorazepam among the controlled members.

Estonia, Benzodiazepines, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73, which controls named members of the family including alprazolam, diazepam and lorazepam and prints no entry for the family label itself · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Benzodiazepines in Estonia, full detail →

Buprenorphine

Legal status: Buprenorphine is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for buprenorphine reads «Buprenorfiin». The source does not state whether that entry names buprenorphine itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for buprenorphine, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of buprenorphine can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of buprenorphine is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for buprenorphine. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for buprenorphine names the annex and the entry «Buprenorfiin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for buprenorphine as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for buprenorphine in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for buprenorphine appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Buprenorfiin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Buprenorphine, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Buprenorfiin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Buprenorphine in Estonia, full detail →

Caffeine

Legal status: Caffeine is not listed in the Estonian narcotic and psychotropic schedule. No entry for caffeine was located in Lists I to VI of Annex 1. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to caffeine by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach caffeine, because those penalties attach to the narcotic schedule and caffeine is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that caffeine is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for caffeine in Estonia, because the narcotic schedule does not carry it. The governing regime is no regime named in what was read, which is a gap rather than a permission. Whether caffeine is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for caffeine as unread rather than as open.
Documentation: Carry caffeine as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for caffeine and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for caffeine appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Caffeine, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for caffeine, and records no search terms for this row · the governing regime recorded by the source is no regime named in what was read, which is a gap rather than a permission · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Caffeine in Estonia, full detail →

Cannabinol

Legal status: Cannabinol is not listed in the Estonian narcotic and psychotropic schedule. No entry for cannabinol was located in Lists I to VI of Annex 1. Cannabinol is not separately listed, and a product can still be caught through the cannabinoids that are listed. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to cannabinol by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach cannabinol, because those penalties attach to the narcotic schedule and cannabinol is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that cannabinol is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for cannabinol in Estonia, because the narcotic schedule does not carry it. The governing regime is no regime named in what was read, which is a gap rather than a permission. Whether cannabinol is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for cannabinol as unread rather than as open.
Documentation: Carry cannabinol as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for cannabinol and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for cannabinol appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Cannabinol, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for cannabinol, and records no search terms for this row · the governing regime recorded by the source is no regime named in what was read, which is a gap rather than a permission · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Cannabinol in Estonia, full detail →

Cannabis / THC

Legal status: Cannabis is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for cannabis reads «Kanep; cannabis». The source does not state whether that entry names cannabis itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for cannabis, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of cannabis can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of cannabis is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for cannabis. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for cannabis names the annex and the entry «Kanep; cannabis» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for cannabis as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for cannabis in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for cannabis appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Kanep; cannabis» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Cannabis, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Kanep · cannabis» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Cannabis / THC in Estonia, full detail →

Cathinone

Legal status: Cathinone is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for cathinone reads «Katinoon». The source does not state whether that entry names cathinone itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for cathinone, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of cathinone can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of cathinone is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for cathinone. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for cathinone names the annex and the entry «Katinoon» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for cathinone as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for cathinone in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for cathinone appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Katinoon» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Cathinone, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Katinoon» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Cathinone in Estonia, full detail →

CBD

Legal status: CBD is not listed in the Estonian narcotic and psychotropic schedule. No entry for CBD was located in Lists I to VI of Annex 1. Cannabidiol is not separately listed, and that is not the end of the question: a product can still be caught through tetrahydrocannabinol or another scheduled constituent it contains. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to CBD by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach CBD, because those penalties attach to the narcotic schedule and CBD is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that CBD is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for CBD in Estonia, because the narcotic schedule does not carry it. The governing regime is no regime named in what was read, which is a gap rather than a permission. Whether CBD is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for CBD as unread rather than as open.
Documentation: Carry CBD as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for CBD and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for CBD appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, CBD, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for CBD, and records no search terms for this row · the governing regime recorded by the source is no regime named in what was read, which is a gap rather than a permission · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

CBD in Estonia, full detail →

Clonazepam

Legal status: Clonazepam is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for clonazepam reads «Klonasepaam». The source does not state whether that entry names clonazepam itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for clonazepam, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of clonazepam can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of clonazepam is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for clonazepam. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for clonazepam names the annex and the entry «Klonasepaam» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for clonazepam as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for clonazepam in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for clonazepam appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Klonasepaam» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Clonazepam, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Klonasepaam» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Clonazepam in Estonia, full detail →

Cocaine

Legal status: Cocaine is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for cocaine reads «Kokaiin». That same entry is the one relied on for Crack cocaine, so it is not specific to cocaine and the row rests on a shared entry rather than on a name of its own. The source does not state whether that entry names cocaine itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for cocaine, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of cocaine can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of cocaine is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for cocaine. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for cocaine names the annex and the entry «Kokaiin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for cocaine as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for cocaine in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for cocaine appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Kokaiin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Cocaine, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Kokaiin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Cocaine in Estonia, full detail →

Codeine

Legal status: Codeine is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for codeine reads «Kodeiin». The source does not state whether that entry names codeine itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for codeine, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of codeine can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of codeine is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for codeine. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for codeine names the annex and the entry «Kodeiin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for codeine as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for codeine in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for codeine appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Kodeiin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Codeine, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Kodeiin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Codeine in Estonia, full detail →

Crack Cocaine

Legal status: Crack cocaine is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for crack cocaine reads «Kokaiin». That same entry is the one relied on for Cocaine, so it is not specific to crack cocaine and the row rests on a shared entry rather than on a name of its own. The source does not state whether that entry names crack cocaine itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for crack cocaine, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of crack cocaine can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of crack cocaine is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for crack cocaine. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for crack cocaine names the annex and the entry «Kokaiin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for crack cocaine as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for crack cocaine in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for crack cocaine appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Kokaiin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Crack cocaine, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Kokaiin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Crack Cocaine in Estonia, full detail →

Delta-8-THC

Legal status: Delta-8-THC is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for delta-8-THC reads «Delta-8-tetrahüdrokannabinool ja selle derivaadid». The source does not state whether that entry names delta-8-THC itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for delta-8-THC, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of delta-8-THC can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of delta-8-THC is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for delta-8-THC. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for delta-8-THC names the annex and the entry «Delta-8-tetrahüdrokannabinool ja selle derivaadid» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for delta-8-THC as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for delta-8-THC in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for delta-8-THC appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Delta-8-tetrahüdrokannabinool ja selle derivaadid» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Delta-8-THC, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Delta-8-tetrahüdrokannabinool ja selle derivaadid» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Delta-8-THC in Estonia, full detail →

Diazepam

Legal status: Diazepam is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for diazepam reads «Diasepaam». The source does not state whether that entry names diazepam itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for diazepam, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of diazepam can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of diazepam is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for diazepam. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for diazepam names the annex and the entry «Diasepaam» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for diazepam as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for diazepam in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for diazepam appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Diasepaam» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Diazepam, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Diasepaam» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Diazepam in Estonia, full detail →

DMT

Legal status: DMT is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for DMT reads «Dimetüültrüptamiin (DMT)». That same entry is the one relied on for Ayahuasca, so it is not specific to DMT and the row rests on a shared entry rather than on a name of its own. The source does not state whether that entry names DMT itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for DMT, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of DMT can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of DMT is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for DMT. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for DMT names the annex and the entry «Dimetüültrüptamiin (DMT)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for DMT as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for DMT in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for DMT appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Dimetüültrüptamiin (DMT)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, DMT, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Dimetüültrüptamiin (DMT)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

DMT in Estonia, full detail →

DOM

Legal status: DOM is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for DOM reads «STP (DOM)». The source does not state whether that entry names DOM itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for DOM, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of DOM can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of DOM is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for DOM. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for DOM names the annex and the entry «STP (DOM)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for DOM as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for DOM in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for DOM appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «STP (DOM)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, DOM, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «STP (DOM)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

DOM in Estonia, full detail →

DXM

Legal status: DXM is not listed in the Estonian narcotic and psychotropic schedule. It is governed instead by the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. No entry for DXM was located in Lists I to VI of Annex 1. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to DXM by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach DXM, because those penalties attach to the narcotic schedule and DXM is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that DXM is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for DXM in Estonia, because the narcotic schedule does not carry it. The governing regime is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. Whether DXM is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for DXM as unread rather than as open.
Documentation: Carry DXM as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for DXM and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for DXM appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, DXM, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for DXM, and records no search terms for this row · the governing regime recorded by the source is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

DXM in Estonia, full detail →

Ephedrine

Legal status: Ephedrine is not listed in the Estonian narcotic and psychotropic schedule. It is governed instead by the drug precursor control regime, lähteainete kontroll, rather than the Penal Code narcotic quantity rule. No entry for ephedrine was located in Lists I to VI of Annex 1. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to ephedrine by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach ephedrine, because those penalties attach to the narcotic schedule and ephedrine is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that ephedrine is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for ephedrine in Estonia, because the narcotic schedule does not carry it. The governing regime is the drug precursor control regime, lähteainete kontroll, rather than the Penal Code narcotic quantity rule. Whether ephedrine is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for ephedrine as unread rather than as open.
Documentation: Carry ephedrine as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for ephedrine and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for ephedrine appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Ephedrine, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for ephedrine, and records no search terms for this row · the governing regime recorded by the source is the drug precursor control regime, lähteainete kontroll, rather than the Penal Code narcotic quantity rule · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Ephedrine in Estonia, full detail →

Etizolam

Legal status: Etizolam is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for etizolam reads «Etisolaam». The source does not state whether that entry names etizolam itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for etizolam, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of etizolam can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of etizolam is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for etizolam. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for etizolam names the annex and the entry «Etisolaam» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for etizolam as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for etizolam in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for etizolam appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Etisolaam» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Etizolam, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Etisolaam» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Etizolam in Estonia, full detail →

Fentanyl

Legal status: Fentanyl is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for fentanyl reads «Fentanüül». The source does not state whether that entry names fentanyl itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for fentanyl, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of fentanyl can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of fentanyl is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for fentanyl. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for fentanyl names the annex and the entry «Fentanüül» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for fentanyl as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for fentanyl in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for fentanyl appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Fentanüül» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Fentanyl, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Fentanüül» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Fentanyl in Estonia, full detail →

Gabapentin

Legal status: Gabapentin is not listed in the Estonian narcotic and psychotropic schedule. It is governed instead by the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. No entry for gabapentin was located in Lists I to VI of Annex 1. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to gabapentin by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach gabapentin, because those penalties attach to the narcotic schedule and gabapentin is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that gabapentin is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for gabapentin in Estonia, because the narcotic schedule does not carry it. The governing regime is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. Whether gabapentin is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for gabapentin as unread rather than as open.
Documentation: Carry gabapentin as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for gabapentin and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for gabapentin appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Gabapentin, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for gabapentin, and records no search terms for this row · the governing regime recorded by the source is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Gabapentin in Estonia, full detail →

GBL

Legal status: GBL is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for GBL reads «Gammabutürolaktoon (GBL)». The source does not state whether that entry names GBL itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for GBL, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of GBL can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of GBL is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for GBL. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for GBL names the annex and the entry «Gammabutürolaktoon (GBL)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for GBL as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for GBL in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for GBL appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Gammabutürolaktoon (GBL)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, GBL, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Gammabutürolaktoon (GBL)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

GBL in Estonia, full detail →

GHB

Legal status: GHB is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for GHB reads «Gammahüdroksübutüraat (GHB)». The source does not state whether that entry names GHB itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for GHB, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of GHB can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of GHB is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for GHB. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for GHB names the annex and the entry «Gammahüdroksübutüraat (GHB)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for GHB as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for GHB in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for GHB appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Gammahüdroksübutüraat (GHB)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, GHB, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Gammahüdroksübutüraat (GHB)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

GHB in Estonia, full detail →

Heroin

Legal status: Heroin is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for heroin reads «Heroiin (diatsetüülmorfiin)». The source does not state whether that entry names heroin itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for heroin, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of heroin can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of heroin is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for heroin. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for heroin names the annex and the entry «Heroiin (diatsetüülmorfiin)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for heroin as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for heroin in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for heroin appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Heroiin (diatsetüülmorfiin)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Heroin, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Heroiin (diatsetüülmorfiin)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Heroin in Estonia, full detail →

HHC

Legal status: HHC is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for HHC reads «Heksahüdrokannabinool (HHC)». The source does not state whether that entry names HHC itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for HHC, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of HHC can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of HHC is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for HHC. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for HHC names the annex and the entry «Heksahüdrokannabinool (HHC)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for HHC as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for HHC in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for HHC appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Heksahüdrokannabinool (HHC)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, HHC, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Heksahüdrokannabinool (HHC)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

HHC in Estonia, full detail →

Hydrocodone

Legal status: Hydrocodone is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for hydrocodone reads «Hüdrokodoon». The source does not state whether that entry names hydrocodone itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for hydrocodone, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of hydrocodone can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of hydrocodone is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for hydrocodone. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for hydrocodone names the annex and the entry «Hüdrokodoon» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for hydrocodone as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for hydrocodone in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for hydrocodone appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Hüdrokodoon» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Hydrocodone, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Hüdrokodoon» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Hydrocodone in Estonia, full detail →

Ketamine

Legal status: Ketamine is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for ketamine reads «Ketamiin». The source does not state whether that entry names ketamine itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for ketamine, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of ketamine can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of ketamine is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for ketamine. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for ketamine names the annex and the entry «Ketamiin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for ketamine as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for ketamine in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for ketamine appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Ketamiin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Ketamine, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Ketamiin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Ketamine in Estonia, full detail →

Khat

Legal status: Khat is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for khat reads «Katinoon; katiin». The source does not state whether that entry names khat itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for khat, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of khat can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of khat is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for khat. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for khat names the annex and the entry «Katinoon; katiin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for khat as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for khat in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for khat appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Katinoon; katiin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Khat, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Katinoon · katiin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Khat in Estonia, full detail →

Kratom

Legal status: Kratom is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for kratom reads «Mitragüniin; 7-hüdroksümitragüniin». The source does not state whether that entry names kratom itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for kratom, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of kratom can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of kratom is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for kratom. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for kratom names the annex and the entry «Mitragüniin; 7-hüdroksümitragüniin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for kratom as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for kratom in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for kratom appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Mitragüniin; 7-hüdroksümitragüniin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Kratom, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Mitragüniin · 7-hüdroksümitragüniin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Kratom in Estonia, full detail →

Lorazepam

Legal status: Lorazepam is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for lorazepam reads «Lorasepaam». The source does not state whether that entry names lorazepam itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for lorazepam, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of lorazepam can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of lorazepam is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for lorazepam. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for lorazepam names the annex and the entry «Lorasepaam» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for lorazepam as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for lorazepam in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for lorazepam appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Lorasepaam» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Lorazepam, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Lorasepaam» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Lorazepam in Estonia, full detail →

LSA (Morning Glory)

Legal status: LSA is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for LSA reads «Lüsergiinhape ja selle derivaadid». The source does not state whether that entry names LSA itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for LSA, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of LSA can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of LSA is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for LSA. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for LSA names the annex and the entry «Lüsergiinhape ja selle derivaadid» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for LSA as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for LSA in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for LSA appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Lüsergiinhape ja selle derivaadid» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, LSA, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Lüsergiinhape ja selle derivaadid» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

LSA (Morning Glory) in Estonia, full detail →

LSD

Legal status: LSD is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for LSD reads «Lüsergiinhappe dietüülamiid (LSD)». The source does not state whether that entry names LSD itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for LSD, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of LSD can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of LSD is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for LSD. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for LSD names the annex and the entry «Lüsergiinhappe dietüülamiid (LSD)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for LSD as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for LSD in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for LSD appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Lüsergiinhappe dietüülamiid (LSD)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, LSD, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Lüsergiinhappe dietüülamiid (LSD)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

LSD in Estonia, full detail →

MDA

Legal status: MDA is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for MDA reads «Tenamfetamiin (MDA)». The source does not state whether that entry names MDA itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for MDA, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of MDA can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of MDA is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for MDA. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for MDA names the annex and the entry «Tenamfetamiin (MDA)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for MDA as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for MDA in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for MDA appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Tenamfetamiin (MDA)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, MDA, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Tenamfetamiin (MDA)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

MDA in Estonia, full detail →

MDMA

Legal status: MDMA is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for MDMA reads «Metüleendioksümetamfetamiin (MDMA)». The source does not state whether that entry names MDMA itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for MDMA, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of MDMA can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of MDMA is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for MDMA. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for MDMA names the annex and the entry «Metüleendioksümetamfetamiin (MDMA)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for MDMA as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for MDMA in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for MDMA appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Metüleendioksümetamfetamiin (MDMA)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, MDMA, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Metüleendioksümetamfetamiin (MDMA)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

MDMA in Estonia, full detail →

MDPV

Legal status: MDPV is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for MDPV reads «Metüleendioksüpürovaleroon (MDPV)». The source does not state whether that entry names MDPV itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for MDPV, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of MDPV can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of MDPV is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for MDPV. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for MDPV names the annex and the entry «Metüleendioksüpürovaleroon (MDPV)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for MDPV as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for MDPV in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for MDPV appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Metüleendioksüpürovaleroon (MDPV)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, MDPV, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Metüleendioksüpürovaleroon (MDPV)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

MDPV in Estonia, full detail →

Memantine

Legal status: Memantine is not listed in the Estonian narcotic and psychotropic schedule. It is governed instead by the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. No entry for memantine was located in Lists I to VI of Annex 1. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to memantine by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach memantine, because those penalties attach to the narcotic schedule and memantine is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that memantine is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for memantine in Estonia, because the narcotic schedule does not carry it. The governing regime is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. Whether memantine is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for memantine as unread rather than as open.
Documentation: Carry memantine as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for memantine and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for memantine appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Memantine, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for memantine, and records no search terms for this row · the governing regime recorded by the source is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Memantine in Estonia, full detail →

Mephedrone (4-MMC)

Legal status: Mephedrone is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for mephedrone reads «4-metüülmetkatinoon (mefedroon, 4-MMC)». The source does not state whether that entry names mephedrone itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for mephedrone, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of mephedrone can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of mephedrone is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for mephedrone. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for mephedrone names the annex and the entry «4-metüülmetkatinoon (mefedroon, 4-MMC)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for mephedrone as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for mephedrone in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for mephedrone appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «4-metüülmetkatinoon (mefedroon, 4-MMC)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Mephedrone, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «4-metüülmetkatinoon (mefedroon, 4-MMC)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Mephedrone (4-MMC) in Estonia, full detail →

Mescaline

Legal status: Mescaline is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for mescaline reads «Meskaliin». That same entry is the one relied on for Peyote, so it is not specific to mescaline and the row rests on a shared entry rather than on a name of its own. The source does not state whether that entry names mescaline itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for mescaline, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of mescaline can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of mescaline is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for mescaline. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for mescaline names the annex and the entry «Meskaliin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for mescaline as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for mescaline in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for mescaline appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Meskaliin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Mescaline, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Meskaliin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Mescaline in Estonia, full detail →

Methadone

Legal status: Methadone is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for methadone reads «Metadoon». The source does not state whether that entry names methadone itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for methadone, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of methadone can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of methadone is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for methadone. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for methadone names the annex and the entry «Metadoon» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for methadone as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for methadone in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for methadone appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Metadoon» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Methadone, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Metadoon» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Methadone in Estonia, full detail →

Methamphetamine

Legal status: Methamphetamine is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for methamphetamine reads «Metamfetamiin». The source does not state whether that entry names methamphetamine itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for methamphetamine, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of methamphetamine can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of methamphetamine is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for methamphetamine. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for methamphetamine names the annex and the entry «Metamfetamiin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for methamphetamine as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for methamphetamine in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for methamphetamine appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Metamfetamiin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Methamphetamine, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Metamfetamiin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Methamphetamine in Estonia, full detail →

Methaqualone (Quaaludes)

Legal status: Methaqualone is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for methaqualone reads «Metakvaloon». The source does not state whether that entry names methaqualone itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for methaqualone, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of methaqualone can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of methaqualone is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for methaqualone. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for methaqualone names the annex and the entry «Metakvaloon» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for methaqualone as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for methaqualone in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for methaqualone appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Metakvaloon» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Methaqualone, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Metakvaloon» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Methaqualone (Quaaludes) in Estonia, full detail →

Methylone

Legal status: Methylone is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for methylone reads «3,4-metüleendioksümetkatinoon (metüloon, bk-MDMA)». The source does not state whether that entry names methylone itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for methylone, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of methylone can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of methylone is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for methylone. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for methylone names the annex and the entry «3,4-metüleendioksümetkatinoon (metüloon, bk-MDMA)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for methylone as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for methylone in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for methylone appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «3,4-metüleendioksümetkatinoon (metüloon, bk-MDMA)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Methylone, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «3,4-metüleendioksümetkatinoon (metüloon, bk-MDMA)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Methylone in Estonia, full detail →

Methylphenidate

Legal status: Methylphenidate is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for methylphenidate reads «Metüülfenidaat». The source does not state whether that entry names methylphenidate itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for methylphenidate, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of methylphenidate can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of methylphenidate is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for methylphenidate. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for methylphenidate names the annex and the entry «Metüülfenidaat» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for methylphenidate as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for methylphenidate in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for methylphenidate appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Metüülfenidaat» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Methylphenidate, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Metüülfenidaat» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Methylphenidate in Estonia, full detail →

Mitragynine

Legal status: Mitragynine is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for mitragynine reads «Mitragüniin». The source does not state whether that entry names mitragynine itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for mitragynine, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of mitragynine can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of mitragynine is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for mitragynine. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for mitragynine names the annex and the entry «Mitragüniin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for mitragynine as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for mitragynine in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for mitragynine appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Mitragüniin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Mitragynine, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Mitragüniin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Mitragynine in Estonia, full detail →

Modafinil

Legal status: Modafinil is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for modafinil reads «Modafiniil». The source does not state whether that entry names modafinil itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for modafinil, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of modafinil can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of modafinil is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for modafinil. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for modafinil names the annex and the entry «Modafiniil» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for modafinil as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for modafinil in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for modafinil appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Modafiniil» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Modafinil, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Modafiniil» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Modafinil in Estonia, full detail →

Morphine

Legal status: Morphine is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for morphine reads «Morfiin». The source does not state whether that entry names morphine itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for morphine, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of morphine can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of morphine is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for morphine. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for morphine names the annex and the entry «Morfiin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for morphine as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for morphine in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for morphine appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Morfiin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Morphine, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Morfiin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Morphine in Estonia, full detail →

MXE

Legal status: MXE is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for MXE reads «Metoksetamiin (MXE)». The source does not state whether that entry names MXE itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for MXE, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of MXE can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of MXE is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for MXE. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for MXE names the annex and the entry «Metoksetamiin (MXE)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for MXE as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for MXE in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for MXE appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Metoksetamiin (MXE)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, MXE, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Metoksetamiin (MXE)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

MXE in Estonia, full detail →

Nicotine

Legal status: Nicotine is not listed in the Estonian narcotic and psychotropic schedule. It is governed instead by the Tobacco Act, Tubakaseadus, which is a separate regulatory regime and not the narcotic schedule. No entry for nicotine was located in Lists I to VI of Annex 1. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to nicotine by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach nicotine, because those penalties attach to the narcotic schedule and nicotine is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that nicotine is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for nicotine in Estonia, because the narcotic schedule does not carry it. The governing regime is the Tobacco Act, Tubakaseadus, which is a separate regulatory regime and not the narcotic schedule. Whether nicotine is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for nicotine as unread rather than as open.
Documentation: Carry nicotine as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for nicotine and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for nicotine appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Nicotine, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for nicotine, and records no search terms for this row · the governing regime recorded by the source is the Tobacco Act, Tubakaseadus, which is a separate regulatory regime and not the narcotic schedule · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Nicotine in Estonia, full detail →

Nimetazepam

Legal status: Nimetazepam is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for nimetazepam reads «Nimetasepaam». The source does not state whether that entry names nimetazepam itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for nimetazepam, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of nimetazepam can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of nimetazepam is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for nimetazepam. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for nimetazepam names the annex and the entry «Nimetasepaam» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for nimetazepam as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for nimetazepam in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for nimetazepam appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Nimetasepaam» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Nimetazepam, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Nimetasepaam» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Nimetazepam in Estonia, full detail →

Nitrous Oxide

Legal status: Nitrous oxide is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for nitrous oxide reads «Dilämmastikoksiid». The source does not state whether that entry names nitrous oxide itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for nitrous oxide, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. This substance is the one the schedule review dates most recently: nitrous oxide was brought under control in List V after the earlier amendment, which is why the horizon on this row matters more than on most.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of nitrous oxide can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of nitrous oxide is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for nitrous oxide. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for nitrous oxide names the annex and the entry «Dilämmastikoksiid» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for nitrous oxide as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for nitrous oxide in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for nitrous oxide appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Dilämmastikoksiid» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Nitrous oxide, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Dilämmastikoksiid» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Nitrous Oxide in Estonia, full detail →

Opium

Legal status: Opium is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for opium reads «Oopium». The source does not state whether that entry names opium itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for opium, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of opium can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of opium is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for opium. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for opium names the annex and the entry «Oopium» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for opium as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for opium in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for opium appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Oopium» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Opium, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Oopium» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Opium in Estonia, full detail →

Oxycodone

Legal status: Oxycodone is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for oxycodone reads «Oksükodoon». The source does not state whether that entry names oxycodone itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for oxycodone, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of oxycodone can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of oxycodone is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for oxycodone. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for oxycodone names the annex and the entry «Oksükodoon» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for oxycodone as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for oxycodone in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for oxycodone appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Oksükodoon» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Oxycodone, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Oksükodoon» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Oxycodone in Estonia, full detail →

PCP

Legal status: PCP is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for PCP reads «Fentsüklidiin (PCP)». The source does not state whether that entry names PCP itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for PCP, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of PCP can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of PCP is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for PCP. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for PCP names the annex and the entry «Fentsüklidiin (PCP)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for PCP as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for PCP in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for PCP appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Fentsüklidiin (PCP)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, PCP, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Fentsüklidiin (PCP)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

PCP in Estonia, full detail →

Peyote

Legal status: Peyote is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for peyote reads «Meskaliin». That same entry is the one relied on for Mescaline, so it is not specific to peyote and the row rests on a shared entry rather than on a name of its own. The source does not state whether that entry names peyote itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for peyote, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of peyote can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of peyote is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for peyote. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for peyote names the annex and the entry «Meskaliin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for peyote as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for peyote in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for peyote appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Meskaliin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Peyote, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Meskaliin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Peyote in Estonia, full detail →

Phenibut

Legal status: Phenibut is not listed in the Estonian narcotic and psychotropic schedule. It is governed instead by the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. No entry for phenibut was located in Lists I to VI of Annex 1. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to phenibut by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach phenibut, because those penalties attach to the narcotic schedule and phenibut is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that phenibut is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for phenibut in Estonia, because the narcotic schedule does not carry it. The governing regime is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. Whether phenibut is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for phenibut as unread rather than as open.
Documentation: Carry phenibut as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for phenibut and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for phenibut appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Phenibut, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for phenibut, and records no search terms for this row · the governing regime recorded by the source is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Phenibut in Estonia, full detail →

Pink Cocaine / Tusi

Legal status: Pink cocaine is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for pink cocaine reads «segu, mille õiguslik seisund järgib tuvastatud koostisosi». That entry is a category rather than a substance name, so the row rests on the category and on whatever constituents are identified. The source does not state whether that entry names pink cocaine itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for pink cocaine, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of pink cocaine can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of pink cocaine is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for pink cocaine. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for pink cocaine names the annex and the entry «segu, mille õiguslik seisund järgib tuvastatud koostisosi» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for pink cocaine as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for pink cocaine in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for pink cocaine appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «segu, mille õiguslik seisund järgib tuvastatud koostisosi» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Pink cocaine, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «segu, mille õiguslik seisund järgib tuvastatud koostisosi» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Pink Cocaine / Tusi in Estonia, full detail →

Poppers

Legal status: Poppers is not listed in the Estonian narcotic and psychotropic schedule. No entry for poppers was located in Lists I to VI of Annex 1. The product label does not itself identify a listed substance, so the answer depends on the alkyl nitrite actually present. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to poppers by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach poppers, because those penalties attach to the narcotic schedule and poppers is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that poppers is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for poppers in Estonia, because the narcotic schedule does not carry it. The governing regime is no regime named in what was read, which is a gap rather than a permission. Whether poppers is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for poppers as unread rather than as open.
Documentation: Carry poppers as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for poppers and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for poppers appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Poppers, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for poppers, and records no search terms for this row · the governing regime recorded by the source is no regime named in what was read, which is a gap rather than a permission · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Poppers in Estonia, full detail →

Pregabalin

Legal status: Pregabalin is not listed in the Estonian narcotic and psychotropic schedule. It is governed instead by the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. No entry for pregabalin was located in Lists I to VI of Annex 1. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to pregabalin by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach pregabalin, because those penalties attach to the narcotic schedule and pregabalin is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that pregabalin is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for pregabalin in Estonia, because the narcotic schedule does not carry it. The governing regime is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. Whether pregabalin is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for pregabalin as unread rather than as open.
Documentation: Carry pregabalin as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for pregabalin and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for pregabalin appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Pregabalin, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for pregabalin, and records no search terms for this row · the governing regime recorded by the source is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Pregabalin in Estonia, full detail →

Psilocybin

Legal status: Psilocybin is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for psilocybin reads «Psilotsübiin». The source does not state whether that entry names psilocybin itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for psilocybin, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of psilocybin can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of psilocybin is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for psilocybin. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for psilocybin names the annex and the entry «Psilotsübiin» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for psilocybin as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for psilocybin in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for psilocybin appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Psilotsübiin» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Psilocybin, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Psilotsübiin» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Psilocybin in Estonia, full detail →

Quetiapine

Legal status: Quetiapine is not listed in the Estonian narcotic and psychotropic schedule. It is governed instead by the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. No entry for quetiapine was located in Lists I to VI of Annex 1. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to quetiapine by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach quetiapine, because those penalties attach to the narcotic schedule and quetiapine is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that quetiapine is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for quetiapine in Estonia, because the narcotic schedule does not carry it. The governing regime is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. Whether quetiapine is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for quetiapine as unread rather than as open.
Documentation: Carry quetiapine as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for quetiapine and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for quetiapine appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Quetiapine, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for quetiapine, and records no search terms for this row · the governing regime recorded by the source is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Quetiapine in Estonia, full detail →

Salvia divinorum

Legal status: Salvia divinorum is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for Salvia divinorum reads «Salvinoriin A». The source does not state whether that entry names Salvia divinorum itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for Salvia divinorum, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of Salvia divinorum can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of Salvia divinorum is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for Salvia divinorum. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for Salvia divinorum names the annex and the entry «Salvinoriin A» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for Salvia divinorum as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for Salvia divinorum in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for Salvia divinorum appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Salvinoriin A» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Salvia divinorum, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Salvinoriin A» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Salvia divinorum in Estonia, full detail →

Scopolamine (Devil's Breath)

Legal status: Scopolamine is not listed in the Estonian narcotic and psychotropic schedule. It is governed instead by the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. No entry for scopolamine was located in Lists I to VI of Annex 1. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to scopolamine by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach scopolamine, because those penalties attach to the narcotic schedule and scopolamine is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that scopolamine is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for scopolamine in Estonia, because the narcotic schedule does not carry it. The governing regime is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. Whether scopolamine is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for scopolamine as unread rather than as open.
Documentation: Carry scopolamine as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for scopolamine and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for scopolamine appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Scopolamine, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for scopolamine, and records no search terms for this row · the governing regime recorded by the source is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Scopolamine (Devil's Breath) in Estonia, full detail →

Synthetic Cannabinoids (K2 / Spice)

Legal status: Synthetic cannabinoids is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for synthetic cannabinoids reads «nimekirja kantud sünteetilised kannabinoidid ja ainerühmad». That entry is a category rather than a substance name, so the row rests on the category and on whatever constituents are identified. The source does not state whether that entry names synthetic cannabinoids itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for synthetic cannabinoids, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of synthetic cannabinoids can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of synthetic cannabinoids is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for synthetic cannabinoids. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for synthetic cannabinoids names the annex and the entry «nimekirja kantud sünteetilised kannabinoidid ja ainerühmad» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for synthetic cannabinoids as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for synthetic cannabinoids in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for synthetic cannabinoids appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «nimekirja kantud sünteetilised kannabinoidid ja ainerühmad» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Synthetic cannabinoids, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «nimekirja kantud sünteetilised kannabinoidid ja ainerühmad» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Synthetic Cannabinoids (K2 / Spice) in Estonia, full detail →

THC-P

Legal status: THC-P is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for THC-P reads «Tetrahüdrokannabiforool (THCP)». The source does not state whether that entry names THC-P itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for THC-P, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of THC-P can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of THC-P is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for THC-P. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for THC-P names the annex and the entry «Tetrahüdrokannabiforool (THCP)» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for THC-P as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for THC-P in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for THC-P appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Tetrahüdrokannabiforool (THCP)» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, THC-P, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Tetrahüdrokannabiforool (THCP)» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

THC-P in Estonia, full detail →

Tobacco

Legal status: Tobacco is not listed in the Estonian narcotic and psychotropic schedule. It is governed instead by the Tobacco Act, Tubakaseadus, which is a separate regulatory regime and not the narcotic schedule. No entry for tobacco was located in Lists I to VI of Annex 1. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to tobacco by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach tobacco, because those penalties attach to the narcotic schedule and tobacco is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that tobacco is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for tobacco in Estonia, because the narcotic schedule does not carry it. The governing regime is the Tobacco Act, Tubakaseadus, which is a separate regulatory regime and not the narcotic schedule. Whether tobacco is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for tobacco as unread rather than as open.
Documentation: Carry tobacco as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for tobacco and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for tobacco appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Tobacco, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for tobacco, and records no search terms for this row · the governing regime recorded by the source is the Tobacco Act, Tubakaseadus, which is a separate regulatory regime and not the narcotic schedule · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Tobacco in Estonia, full detail →

Tramadol

Legal status: Tramadol is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for tramadol reads «Tramadool». The source does not state whether that entry names tramadol itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for tramadol, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of tramadol can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of tramadol is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for tramadol. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for tramadol names the annex and the entry «Tramadool» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for tramadol as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for tramadol in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for tramadol appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Tramadool» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Tramadol, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Tramadool» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Tramadol in Estonia, full detail →

Xanax (Alprazolam)

Legal status: Alprazolam is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for alprazolam reads «Alprasolaam». The source does not state whether that entry names alprazolam itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for alprazolam, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of alprazolam can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of alprazolam is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for alprazolam. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for alprazolam names the annex and the entry «Alprasolaam» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for alprazolam as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for alprazolam in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for alprazolam appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Alprasolaam» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Alprazolam, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Alprasolaam» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Xanax (Alprazolam) in Estonia, full detail →

Xylazine

Legal status: Xylazine is not listed in the Estonian narcotic and psychotropic schedule. It is governed instead by the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. No entry for xylazine was located in Lists I to VI of Annex 1. The Narcotic Drugs and Psychotropic Substances Act prohibition therefore does not attach to xylazine by name. This rests on the compiler's statement that no entry appears in Annex 1 to Minister of Social Affairs Regulation No 73, and the source records no search terms for this row, so the absence is weaker evidence than a recorded query would be. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024. An absence is a statement about a list at a moment, and this one is stated as at that date and no later.
Consequences if caught: Capital exposure: none. Estonia has no death penalty and none of the drug penalties reach xylazine, because those penalties attach to the narcotic schedule and xylazine is not on it. The Penal Code drug ceiling of life imprisonment under section 184(2) with a superscript one is therefore not assigned on this record, and neither is the large quantity test at section 3(1)(3) of the Narcotic Drugs and Psychotropic Substances Act. That is not a statement that xylazine is unregulated. It is a statement that the narcotic offence scale is not the instrument that regulates it, and any penalty attaches under the regime that does.
If prescribed / medical: There is no narcotic prescription question for xylazine in Estonia, because the narcotic schedule does not carry it. The governing regime is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic. Whether xylazine is available on prescription, over the counter, or on general sale is a question for that regime, and this row did not audit it. The State Agency of Medicines is the body that answers it for a medicine. Treat the supply route for xylazine as unread rather than as open.
Documentation: Carry xylazine as the governing regime allows and do not rely on this row for a carriage permission, because a substance that is off the narcotic schedule is not thereby free to cross a border. That is the carriage answer for xylazine and it is deliberately narrow. No traveller permit scheme, declaration form or carriage allowance for xylazine appears in what was read here, and an absence in what was read is not proof that no scheme exists. Provenance follows. Annex 1 to Minister of Social Affairs Regulation No 73 was read on 18 September 2026 on Riigi Teataja, the official state gazette, and the source states that no entry appears in Lists I to VI. It records no search terms for this row, which is a limit on how strong that absence can be taken to be.

Estonia, Xylazine, provenance carried from the source compilation, which read Riigi Teataja, the official state gazette of the Republic of Estonia · stated as in force on 18 September 2026 · the source states that Annex 1 to Minister of Social Affairs Regulation No 73, Lists I to VI, carries no entry for xylazine, and records no search terms for this row · the governing regime recorded by the source is the Medicinal Products Act, Ravimiseadus, which governs it as a medicine rather than as a scheduled narcotic · this absence is stated as at the version of Annex 1 in force on 18 September 2026 and the schedule review covers the amendment effective 31 December 2024 · links below are the source compilation's own source map rather than per-row provenance · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Xylazine in Estonia, full detail →

Zolpidem

Legal status: Zolpidem is a controlled substance in Estonia. The national schedule is Annex 1 to Minister of Social Affairs Regulation No 73, and the entry relied on for zolpidem reads «Zolpideem». The source does not state whether that entry names zolpidem itself or a constituent of it, because its explanation column carries one sentence for every controlled row, that the annex names the substance or the applicable controlled entry, and that wording covers both cases. The Narcotic Drugs and Psychotropic Substances Act prohibits handling except for authorised medical, scientific and enforcement purposes, and the annex controls the listed isomers, esters, ethers, salts and medicines as the instrument provides. Estonia publishes no gram figure for zolpidem, because the boundary that decides the offence is a quantity test rather than a weight. This reading is stated as in force on 18 September 2026, the day the instruments were read, and the schedule review covers the amendment effective 31 December 2024.
Consequences if caught: Capital exposure: none. Estonia has no death penalty, so no quantity of zolpidem can carry one. The ceiling is life imprisonment under Penal Code section 184(2) with a superscript one, which is reached when section 184 conduct is committed for large financial gain or by a criminal organisation, and the band immediately below it is 6 to 20 years. Below it the scale runs in three steps: dealing in a small quantity, up to 5 years under Penal Code section 183(2); handling a large quantity, 1 to 10 years under section 184(1); and the aggravated form, 3 to 15 years under section 184(2). What makes a quantity large is not a gram figure. The Narcotic Drugs and Psychotropic Substances Act, at section 3(1)(3), defines a large quantity as an amount sufficient to intoxicate at least ten people, so the prosecution must prove the intoxicating dose rather than weigh the seizure. A claim that Estonia allows a fixed personal quantity of zolpidem is not the statutory rule, and small personal possession or use can remain an offence under the Act even where section 184 is not reached.
If prescribed / medical: There may be a lawful route and this row cannot tell you whether there is one for zolpidem. The Act permits handling for authorised medical, scientific and enforcement purposes, so a medical route exists in principle. Regulation No 73 divides its schedule into six lists, Lists I to VI, and it is the list a substance sits in that decides whether it has a recognised medical use in Estonia. The source read for zolpidem names the annex and the entry «Zolpideem» and does not record which of the six lists carries it. That is a gap in what was read rather than a finding that no route exists, and the State Agency of Medicines is the body that settles it. Treat the prescription route for zolpidem as unread, not as absent.
Documentation: Carry the prescription and the original dispensing packaging, and get the State Agency of Medicines to confirm the position for zolpidem in writing before you travel rather than at the airport. That is the carriage answer and it is deliberately short, because no traveller permit scheme, declaration form or carriage allowance for zolpidem appears anywhere in what was read for this row. An absence in what was read is not proof that no scheme exists. Provenance follows. The entry «Zolpideem» was read in Annex 1 to Minister of Social Affairs Regulation No 73, alongside the Narcotic Drugs and Psychotropic Substances Act and the Penal Code, in their consolidated texts on Riigi Teataja, the official state gazette, on 18 September 2026.

Estonia, Zolpidem, read from Riigi Teataja, the official state gazette of the Republic of Estonia, and from the State Agency of Medicines · read as in force on 18 September 2026 · located at Annex 1 to Minister of Social Affairs Regulation No 73 as «Zolpideem» · the Narcotic Drugs and Psychotropic Substances Act section 3(1)(3) supplies the large quantity test and Penal Code sections 183 and 184 supply the penalties · schedule review covers the amendment effective 31 December 2024 · riigiteataja.ee · riigiteataja.ee · ravimiamet.ee · Updated September 20, 2026

Zolpidem in Estonia, full detail →

Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.

Before you travel

Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.

If you’re detained or arrested abroad

Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →

← All countries Drug index